Tag Archives: AFib

Medicine Wellness Health

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Freescan: the AI-based solution for stroke prevention (Source: © Maisense)

Hsinchu, Taiwan Oct 9th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention. The company now introduces an AI-based solution that can screen stroke through early detection of atrial fibrillation (AFib) which will also be presented at MEDICA 2018 November 12-15 in Düsseldorf, Germany at booth B26/Hall 11 and is a finalist for the MEDICA App COMPETITION.

Every four minutes, someone dies of stroke. Stroke is also a leading cause of long-term disability. Stroke is even called the „silent killer“ because it often come without any warning signs. However, up to 80% of stroke could be preventable by monitoring the major risk factors of stroke at an early stage.

13% of strokes are classified as hemorrhagic stroke. When the arteries of the brain weaken or break, allowing for blood to spread in the brain tissues, hemorrhagic strokes occur. They are most often caused by chronically hypertension. Up to 87% of strokes are classified as ischemic. An ischemic stroke occurs when a clot or a mass blocks a blood vessel, cutting off blood flow to a part of the brain. There are two main risk factors of ischemic strokes: arterial stiffness and atrial fibrillation (AFib).

A research, „Changes in arterial stiffness independently predict stroke in patients with essential hypertension,“ published in 2018 European Society of Cardiology (ESC), shows a demonstrated association and prediction between arterial stiffness and stroke for essential hypertension patients. The Framingham Heart Study (FHS) identified common factors and characteristics contributed to cardiovascular disease. Low-density lipoprotein (LDL), also called the „bad cholesterol“, is a notable enemy of arterial elasticity and fosters arterial stiffness. High LDL level raises the chances of a heart attack because it deposits in the walls of blood vessels that narrows the arteries or even clog. Other risk factors such as age, hypertension, smoking and diabetes are highly related to cardiovascular diseases.

It’s worth noting that patients with AFib have a five-fold increase in risk of stroke compared to those without. It affects 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. The European Heart Rhythm Association (EHRA), who published the aforementioned numbers, released a classification system of AFib-related symptoms in 2014. EHRA also stressed the fatal consequence even if AFib symptoms are not noticeable to patient or they may not feel uncomfortable. „Since an AFib episode can come and go, there may be many patients undetected and therefore they didn“t receive timely treatment. That“s why we take AFib screening seriously as a key measurement for stroke prevention,“ said Benjamin Chiu, CEO of Maisense.

AFib is usually diagnosed on an ECG but if a patient“s symptoms don“t occur while he sees his doctor or if they are back to normal at this point of time, the doctor would not be able to give advice properly. As a result, Maisense presented the Freescan device and the myFreescan App, which deliver an all-in-1 solution, utilizing artificial intelligence (AI) for early AFib detection, arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device. Users adopting Maisense’s solution can assess their risk level of strokes anytime.

From the patient“s perspective, the solution makes it very easy to measure and record all these biomedical signals at any time. Patients can monitor their own health conditions and take action at an early stage. Through the web-based Patient Care System, doctor can also be informed immediately when abnormal incidents occur – if a patient activated this function under doctor-patient privilege. It also provides sufficient data for doctors to make assessment quickly. The option does not only help to avoid unnecessary healthcare spending and time investments but also improves the service efficiency.

As Apple announced its Watch Series 4, which can record ECG and has received FDA approval, it is believed that more and more people are noticing the importance of irregular heart rhythm detection. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in one single device. Maisense“s Freescan has received EU CE medical certification and is now available in Germany. Maisense will also present the solution at the upcoming „MEDICA 2018“ trade fair on November 12-15 in Düsseldorf, Germany, in Hall 11/ booth B26. Freescan has been selected as one of the 10 finalists in the MEDICA App COMPETITION ( https://www.medica-tradefair.com/cgi-bin/md_medica/lib/pub/tt.cgi/MEDICA_App_COMPETITION.html?oid=46182&lang=2&ticket=g_u_e_s_t). The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

For more information on pricing and the availability of Freescan, please visit Mindtec: https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor
and ME Health CHECK: https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Bach Chen, Vice President of business development, Maisense (Source: © Maisense)

Hsinchu, Taiwan Aug 29th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention, today announced the telecardiology system using a portable device „Freescan“ that can measure blood pressure and record ECG simultaneously.

„For most telecardiology systems on the market, they either provide only ECG, or provide both blood pressure and ECG but retrieve them from two independent devices. The more devices there are, the less likely for patients to use all of them regularly.“ said Bach Chen, Vice President of business development, Maisense.

The purpose of Maisense“s telecardiology system is to simplify the measurement procedure for patients. Through the combination of three elements: the Freescan device, the myFreescan App, and the Patient Care web platform, patients can measure blood pressure and ECG with a single device. In addition, doctors are able to monitor patients“ health condition easily through the web-based Patient Care System. Maisense Freescan in combination with the myFreescan App delivers a combined all-in-1 solution utilizing artificial intelligence (AI) for early atrial fibrillation detection (AFib), arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device.

According to World Health Organization (WHO)“s report in May 2018, stroke incidents are globally the second most common cause of death after ischaemic heart disease. Of the 56.9 million deaths worldwide in 2016, almost 6 million died persons died of strokes, this is about 10% of all the accounted deaths. However, up to 80% of strokes may be preventable by monitoring the major risk factors: arterial stiffness, atrial fibrillation (AFib), and hypertension.

The adoption of Maisense“s telecardiology system will enable every user of the solution to assess their risk level of strokes anytime. Therefore then they can take preventive actions to minimize the risk.

Maisense held a session to elaborate telecardiology system at the ESC (European Society of Cardiology) congress in Munich on August 28th.
„I believe that solid researches lead to excellent innovation. Therefore, we continue to push the boundaries on digital health support, and on top of that, we value each opportunity to present our system at conferences or academia“, said Benjamin Chiu, CEO, Maisense.

Maisense is also growing its channel and is actively looking for distributors in the European Union. In Germany, Maisense is excited to have formed a partnership with the well renowned TITAN Commerce and appPeople. TITAN Commerce is a leading distributor for Bio-/Neurofeedback, sportswear technology and wearables based in Germany. appPeople provides worldwide progressive impulses in the field of telemedicine. Freescan is also available in Germany at Mindtec and ME Health CHECK.

Maisense is proud to be a member of the Global Research & Industry Alliance (GLORIA-Semicon) which focuses on future-oriented technology and builds a cooperation platform between universities and the industry. The organization stimulates innovation and introduces Taiwan startup companies to the global market.

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medizin Gesundheit Wellness

ESC Congress 2018: Maisense präsentiert neues Telekardiologie-System

ESC Congress 2018: Maisense präsentiert neues Telekardiologie-System

Bach Chen, Vice President Business Development, Maisense (Bildquelle: © Maisense)

Problemlos Blutdruck messen und gleichzeitig EKG aufzeichnen mit dem Freescan-System

München, 29. August 2018 – Maisense, ein erfolgreiches taiwanesisches Startup, dass sich der Schlaganfallprävention widmet, stellte gestern sein neues Telekardiologie-System auf dem ESC Congress 2018 in München vor, das mit nur einem System Blutdruck messen und gleichzeitig ein EKG aufzeichnen kann.

Das neuartige System soll insbesondere das Messverfahren für Patienten beziehungsweise Endnutzer vereinfachen. Dafür kombiniert es drei Elemente: das Freescan-Gerät, das den Blutdruck messen und gleichzeitig ein EKG aufzeichnen kann, die myFreescan-App, mit der Patienten und gesundheitsbewusste Anwender ihre persönlichen Gesundheitswerte verfolgen können, sowie das Patient Care System, eine Webplattform, mit der behandelnde Mediziner auf Wunsch des Patienten die Möglichkeit haben, dessen Vitalwerte zu überwachen und diesem direkt Ratschläge zu geben.

„Die meisten Telekardiologie-Systeme auf dem Markt erfassen entweder nur das EKG oder aber sowohl Blutdruck als auch EKG, benötigen dafür jedoch zwei unabhängigen Geräten. Je mehr Geräte eingesetzt werden müssen, desto unwahrscheinlicher ist es, dass die Patienten sie regelmäßig verwenden“, erklärte Bach Chen, Vice President Business Development, Maisense.

Dank dieser Kombination können Patienten Blutdruck und EKG mit nur einem Gerät messen und gleichzeitig direkt von ihren Ärzten betreut werden. Gleichzeitig bietet Maisense somit eine All-in-1-Lösung, die mithilfe von künstlicher Intelligenz (AI), die Früherkennung von Vorhofflimmern (AFib) und Arrhythmie (Bradykardie und Tachykardie) sowie der Überwachung von Pulswellengeschwindigkeit und Blutdruck unterstützt.

Einem Bericht der Weltgesundheitsorganisation (WHO) vom Mai 2018 zufolge, sind Schlaganfälle, nach ischämischen Herzerkrankungen, weltweit die zweithäufigste Todesursache. Von den 56,9 Millionen Todesfällen weltweit im Jahr 2016 starben fast 6 Millionen an Schlaganfällen, das sind etwa 10 Prozent dieser Verstorbenen. Dabei könnten bis zu 80 Prozent der Todesfälle durch Schlaganfall vermieden werden, indem die wichtigsten Risikofaktoren – arterielle Steifheit, Vorhofflimmern (AFib) und Hypertonie – überwacht und möglichst früh erkannt werden.

Mit der Einführung seines Telekardiologie-Systems möchte Maisense Patienten und gesundheitsbewusste Anwender künftig die Möglichkeit bieten, ihr Risiko für Schlaganfälle jederzeit abschätzen und so gegebenenfalls frühzeitig Maßnahmen ergreifen zu können.

Maisense stellte die Lösung gestern auf dem ESC Congress (European Society of Cardiology) im Rahmen einer Tagung zum Thema Telekardiologie-Systeme vor. Benjamin Chiu, der CEO von Maisense, erklärte anschließend: „Ich glaube fest daran, dass aus fundierter Forschung herausragenden Innovationen erwachsen können und dass die Grenzen der digitalen Gesundheitsvorsorge Schritt für Schritt erweitert werden. Umso mehr freuen wir uns, unser System auf führenden Konferenzen einem wissenschaftlichen Fachpublikum präsentieren zu dürfen.“

Im Zuge seiner Expansion in Europa erweitert Maisense seine Vertriebskanäle und sucht unter anderem aktiv Distributoren in Europe. In Deutschland arbeitet Maisense bereits mit TITAN Commerce, einem renommierten Distributor für Bio- /Neurofeedback-Lösungen, Sportbekleidungstechnologie und Wearables sowie mit appPeople, einem Entwickler aus dem Bereich medizinische Geräte und mobile Anwendungen, zusammen. Freescan ist in Deutschland auch über Mindtec und ME Health CHECK erhältlich.

***

Über TITAN Commerce
Das breite Produktspektrum von TITAN Commerce umfasst hochmoderne Biotechnologie, Wearables und professionelle Sportswear-Technologien verschiedener bekannter Biofeedback-, Neurofeedback- und Wearable-Hersteller. Das Ziel von TITAN Commerce ist es, seinen Endkunden die technisch innovativsten Produkte zu bieten, die sie bei der Bewältigung täglicher Belastungen wie Stress, Erschöpfung und Konzentrationsdefiziten unterstützen.
Weitere Informationen erhalten Sie unter: www.titan-commerce.com

Über appPeople
Die im Jahr 2011 gegründete appPeople GmbH entwickelt und vertreibt mobile Anwendungen sowie medizinische Geräte. Die innovativen Produkte ermöglichen die regelmäßige Erfassung relevanter Gesundheitsparameter und tragen dazu bei, Behandlungsergebnisse besser zu beurteilen sowie die Lebensqualität der Nutzer zu verbessern. Das dynamisch wachsende Unternehmen arbeitet mit Partnern in Europa und Asien zusammen und ist einer der erfolgreichsten und kreativsten Anbieter in diesem Markt.
Weitere Informationen erhalten Sie unter: www.apppeople.de

Über Maisense:
Maisense ist ein innovatives Start-up, das in der nicht-invasiven, kardiovaskulären Überwachung für den persönlichen Gebrauch in Kombination mit Software für künstliche Intelligenz zur Schlaganfallprävention arbeitet. Dazu gehören auch AFib, Arrhythmie sowie Arteriensteifigkeitserkennung für den professionellen Arztgebrauch. Maisense wurde 2012 vom taiwanischen Wirtschaftsministerium als Unternehmen mit „Best Investment Potential“ ausgezeichnet. Maisense’s Freescan ist das weltweit erste Blutdruckmessgerät ohne Manschette, das direkt am Handgelenk misst und EU CE-zertifiziert ist. Es wurde in Taiwan mit dem National Innovation Award 2015 ausgezeichnet und erreichte den zweiten Platz unter den Top 10 Innovative Health Products auf der Arab Health 2016 in Dubai. Im Jahr 2017 erhielt es vom taiwanesischen Ministerium für Wissenschaft und Technologie den „Coolest Innovative Startups Award“. Weitere Informationen zu Maisense finden Sie unter: www.maisense.com

Firmenkontakt
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
089/ 360363 41
wibke@gcpr.net
http://www.maisense.com/en/

Pressekontakt
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
089/360363 52
laura@gcpr.net
https://www.gcpr.de/